Company Filing History:
1 out of 9 
1 out of 42 
Years Active: 1976-1980
Title: Innovations by Elena Massarani
Introduction
Elena Massarani is a notable inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit activity against various pathogens. With a total of 2 patents, her work has the potential to impact medical treatments significantly.
Latest Patents
Elena Massarani's latest patents include innovative compounds such as substituted dibenzyl ethers and pharmaceutical compositions. These compounds, specifically 2,4-dichloro-4'-phenyl-.alpha.-(N-imidazolyl-methyl)-dibenzyl ether and 2,4-dichloro-4'-phenylthio-.alpha.-(N-imidazolyl-methyl)-dibenzyl ether, demonstrate effectiveness against certain fungi, yeasts, and both gram-positive aerobic and anaerobic bacteria. The preparation of these compounds involves condensing 1-(2',4'-dichlorophenyl)-2-(N-imidazolyl)-ethanol with various chloromethyl and bromomethyl biphenyl derivatives in a solvent, preferably dimethylsulphoxide. Additionally, she has developed therapeutically active 2-aminoalkylthio-3H-1,5-benzodiazepines, which are effective against a broad spectrum of gram-positive bacteria and the APR8 influenza virus.
Career Highlights
Throughout her career, Elena has worked with reputable companies, including Recordati S.A. and Recordati S.A. Chemical and Pharmaceutical Company. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in pharmaceutical research.
Collaborations
Elena has collaborated with notable colleagues such as Dante Nardi and Alberto Tajana. These partnerships have fostered an environment of innovation and creativity, leading to the development of her impactful inventions.
Conclusion
Elena Massarani's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a significant inventor. Her work not only showcases her expertise but also has the potential to improve therapeutic options for various infections.